Gilead Sciences (GILD) Work In Process (2009 - 2015)
Gilead Sciences' (GILD) quarterly Work In Process came in at $542.0 million in Q4 2015, up 8.4% on a YoY basis from $500.0 million in Q4 2014, and up 8.4% quarter-over-quarter from $500.0 million in Q4 2014.
Analysis
Gilead Sciences (GILD) Work In Process (2009 - 2015) Analysis & Trends
Gilead Sciences (GILD) has reported Work In Process for 7 consecutive years, with $542.0 million the latest figure, recorded in Q4 2015.
- For the quarter ending Q4 2015, Work In Process rose 8.4% year-over-year to $542.0 million; the trailing twelve-month figure through Dec 2015 stood at $542.0 million (up 8.4% YoY), and the FY2015 full-year result was $542.0 million, up 8.4% from the prior year.
- Work In Process advanced to $542.0 million in Q4 2015 per GILD's latest filing, from $500.0 million in the prior quarter.
- Across five years, Work In Process topped out at $563.9 million in Q2 2014 and bottomed at $175.5 million in Q3 2011.
- Historically, Work In Process has averaged $398.7 million across 5 years, with a median of $412.9 million in 2013.
- The sharpest annual moves came in 2011 and 2014: Work In Process sank 55.28% in 2011, then advanced 21.08% in 2014.
- Over 5 years, Work In Process stood at $466.5 million in 2011, then retreated by 23.15% to $358.5 million in 2012, then increased by 15.18% to $412.9 million in 2013, then rose by 21.08% to $500.0 million in 2014, then rose by 8.4% to $542.0 million in 2015.
- According to Business Quant data, Work In Process over the past three periods registered $542.0 million, $500.0 million, and $563.9 million for Q4 2015, Q4 2014, and Q2 2014 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Insmed | 27.67 Bn | 26.51 Bn | 358.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 542.00 Mn |
| Dec 31, 2014 | 500.00 Mn |
| Jun 30, 2014 | 563.88 Mn |
| Dec 31, 2013 | 412.95 Mn |
| Dec 31, 2012 | 358.53 Mn |
| Dec 31, 2011 | 466.50 Mn |
| Sep 30, 2011 | 175.55 Mn |
| Jun 30, 2011 | 271.64 Mn |
| Mar 31, 2011 | 296.87 Mn |
| Dec 31, 2010 | 454.65 Mn |
| Sep 30, 2010 | 392.54 Mn |
| Dec 31, 2009 | 392.04 Mn |